Aspiriant LLC’s Gabelli Equity Trust GAB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-10,676
Closed -$58.6K 299
2024
Q3
$58.6K Hold
10,676
﹤0.01% 291
2024
Q2
$55.5K Buy
+10,676
New +$57.5K ﹤0.01% 279
2019
Q2
Sell
-19,458
Closed -$117K 234
2019
Q1
$117K Hold
19,458
0.01% 227
2018
Q4
$97K Hold
19,458
0.01% 222
2018
Q3
$123K Buy
+19,458
New +$123K 0.01% 236

Other funds holding GAB

Aspiriant LLC's GAB Position: Q4 2024 in Review

Aspiriant LLC sold out of Gabelli Equity Trust (GAB) in Q4 2024, closing a stake of 10,676 shares — an estimated $58.6K sold.

Aspiriant LLC first reported a position in GAB in Q3 2018 and held it in 5 quarters. The position peaked at $123K in Q3 2018. 199 funds tracked by Wall St. Rank hold GAB as of Q4 2024.

  • Aspiriant LLC reported no remaining Gabelli Equity Trust position as of Q4 2024 after selling out during the quarter.
  • Aspiriant LLC sold 10,676 Gabelli Equity Trust shares in Q4 2024, an estimated $58.6K.
  • Aspiriant LLC first reported a position in Gabelli Equity Trust in Q3 2018 and held it in 5 quarters.
  • Aspiriant LLC's Gabelli Equity Trust position peaked at $123K in Q3 2018.
  • 199 funds tracked by Wall St. Rank held Gabelli Equity Trust as of Q4 2024.

Based on Aspiriant LLC's 13F filing for Q4 2024, filed 16 Jan 2025.